Treatment of lupus nephritis: immunosuppression, general therapy, dialysis and transplantation.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Clinical and investigative medicine. Medecine clinique et experimentale

• Publication date

  1994-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 7895423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia.

  2010cited by this paper
• Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography

  2004cited by this paper
• Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus.

  1993cited by this paper
• Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.

  1993cited by this paper
• Changing Patterns of Medical Practice: Protein Restriction for Chronic Renal Failure

  1993cited by this paper
• Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide Therapy

  1993cited by this paper
• Immunosuppressive drug therapy in lupus nephritis.

  1993cited by this paper
• Fish oil in lupus nephritis: clinical findings and methodological implications.

  1993cited by this paper
• Intravenous immunoglobulin therapy: magic or black magic.

  1992cited by this paper
• Clinical status of patients after 10 years of lupus nephritis.

  1992cited by this paper
• Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

  1992cited by this paper
• Manipulating the immune system with immune globulin.

  1992cited by this paper
• A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

  1992cited by this paper
• Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group.

  1992cited by this paper
• Role of oxidized low density lipoprotein in atherogenesis.

  1991cited by this paper
• High-dose intravenous IgG treatment and renal function.

  1991cited by this paper
• Limited effects of intravenous IgG in treating systemic lupus erythematosus--associated thrombocytopenia.

  1991cited by this paper
• Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids.

  1990cited by this paper
• Glucocorticoid-induced osteoporosis: pathogenesis and management.

  1990cited by this paper
• Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE.

  1990cited by this paper
• Management of hyperlipidemia of kidney disease.

  1990cited by this paper
• Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group.

  1989cited by this paper
• Ciclosporin in the treatment of lupus nephritis.

  1989cited by this paper
• Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin.

  1989cited by this paper
• Complications of plasma exchange

  1989cited by this paper
• Outcome of the acute glomerular injury in proliferative lupus nephritis.

  1989cited by this paper
• The effect of protein restriction on the progression of renal insufficiency.

  1989cited by this paper
• Restriction of dietary protein and progression of renal failure in diabetic nephropathy.

  1989cited by this paper
• Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus.

  1989cited by this paper
• Nonimmunologic mechanisms of glomerular injury.

  1988cited by this paper
• Prognostic factors in diffuse proliferative lupus glomerulonephritis.

  1988cited by this paper
• Reduction of blood pressure retards the progression of chronic renal failure in man.

  1988cited by this paper
• Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus.

  1988cited by this paper
• Lupus nephritis after total lymphoid irradiation: persistent improvement and reduction of steroid therapy.

  1987cited by this paper
• Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids.

  1987cited by this paper
• Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus.

  1987cited by this paper
• Silent renal disease in systemic lupus erythematosus.

  1987cited by this paper
• Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL/1 strains.

  1986cited by this paper
• Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control.

  1986cited by this paper
• Correlation of renal histology with outcome in children with lupus nephritis.

  1986cited by this paper
• Total lymphoid irradiation in refractory systemic lupus erythematosus.

  1986cited by this paper
• Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.

  1986cited by this paper
• Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity.

  1985cited by this paper
• Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.

  1985cited by this paper
• A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice.

  1985cited by this paper
• Why do patients with lupus nephritis die?

  1985cited by this paper
• Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus.

  1985cited by this paper
• Treatment of intractable lupus nephritis with total lymphoid irradiation.

  1985cited by this paper
• Total lymphoid irradiation therapy in refractory rheumatoid arthritis. Fifteen- to forty-month followup.

  1984cited by this paper
• Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.

  1984cited by this paper
• Prospective randomised trial of early dietary protein restriction in chronic renal failure.

  1984cited by this paper
• End-stage renal failure in systemic lupus erythematosus with nephritis.

  1984cited by this paper
• Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.

  1984cited by this paper
• Side effects of systemic cyclosporine in patients not undergoing transplantation.

  1984cited by this paper
• Effects of dietary enrichment with eicosapentaenoic acid upon autoimmune nephritis in female NZB X NZW/F1 mice.

  1983cited by this paper
• The long-term clinical course of systemic lupus erythematosus in end-stage renal disease.

  1983cited by this paper
• Randomised trial of plasma exchange in mild systemic lupus erythematosus.

  1983cited by this paper
• Steroid-induced fractures and bone loss in patients with asthma.

  1983cited by this paper
• Prognostic factors in lupus nephritis. Contribution of renal histologic data.

  1983cited by this paper
• Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

  1983cited by this paper
• The information content from renal biopsy in systemic lupus erythematosus.

  1982cited by this paper
• Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy

  1982cited by this paper
• Pulse methylprednisolone in SLE.

  1982cited by this paper
• Hydroxychloroquine. Seven-year experience.

  1982cited by this paper
• Natural history of "silent" lupus nephritis.

  1982cited by this paper
• A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death.

  1982cited by this paper
• Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.

  1982cited by this paper
• Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.

  1982cited by this paper
• Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methylprednisolone.

  1982cited by this paper
• Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice.

  1981cited by this paper
• Antimalarial Therapy for Lupus Erythematosus: An Apparent Advantage of Quinacrine

  1981cited by this paper
• Idiopathic necrosis of the femoral head: pathogenesis and treatment.

  1981cited by this paper
• Coronary arterial disease in systemic lupus erythematosus; quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years.

  1981cited by this paper
• Lymphoma in renal allograft patients treated with cyclosporin-A as one of the immunosuppressive agents.

  1981cited by this paper
• Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis.

  1979cited by this paper
• Mortality in lupus nephritis.

  1979cited by this paper
• Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus?

  1979cited by this paper
• Avascular necrosis in systemic lupus erythematosus. Silent symmetric osteonecroses.

  1979cited by this paper
• Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus.

  1978cited by this paper
• The treatment of lupus nephritis by methyl prednisolone pulse therapy.

  1978cited by this paper
• Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis.

  1976cited by this paper
• ISCHEMIC NECROSIS OF BONE IN SYSTEMIC LUPUS ERYTHEMATOSUS

  1976cited by this paper
• Avascular necrosis in SLE. An apparent predilection for young patients.

  1976cited by this paper
• The bimodal mortality pattern of systemic lupus erythematosus.

  1976cited by this paper
• Therapy and prognosis of hypertension in chronic nephritis.

  1975cited by this paper
• Incidence of infection in systemic lupus erythematosus.

  1974cited by this paper
• Avascular necrosis of bone in systemic lupus erythematosus.

  1974cited by this paper
• Duration and death in systemic lupus erythematosus. An analysis of 249 cases.

  1974cited by this paper
• The clinical course of the proliferative and membranous forms of lupus nephritis.

  1970cited by this paper
• THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS.

  1964cited by this paper
• Factors influencing the course and prognosis of systemic lupus erythematosus.

  1959cited by this paper
• Effects of cortisone on acute disseminated lupus erythematosus.

  1951cited by this paper
• The effect of adrenocorticotropic hormone (ACTH) and cortisone on the course of disseminated lupus erythematosus and peri-arteritis nodosa.

  1950cited by this paper

• Fish oil for kidney transplant recipients.

  2016cites this paper
• Treatment of Lupus Nephritis

  2012cites this paper
• Fish oil for kidney transplant recipients.

  2007cites this paper
• Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.

  2006cites this paper
• SLEN2 (2q34-35) and SLEN1 (10q22.3) replication in systemic lupus erythematosus stratified by nephritis.

  2004cites this paper
• Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine.

  2003cites this paper
• The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3)

  2002cites this paper
• Anti-DNA autoantibodies and systemic lupus erythematosus.

  1999cites this paper